Discovery of Potent and Orally Bioavailable Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for the Treatment of Osteosarcoma.
Chen X, Liu L, Liu P, Chen Y, Lin D, Yan H, Yan Q, Wang Y, Qiu Y, Fang B, Huang H, Qian J, Zhao Y, Du Z, Zhang Q, Li X, Zheng X, Liu Z.
Chen X, et al. Among authors: fang b.
J Med Chem. 2022 Apr 14;65(7):5374-5391. doi: 10.1021/acs.jmedchem.1c01732. Epub 2022 Mar 3.
J Med Chem. 2022.
PMID: 35239349